Market Overview

10 Biggest Mid-Day Gainers For Friday

  • Marinus Pharmaceuticals Inc (NASDAQ: MRNS) surged 34.1 percent to $1.12 as the company disclosed that ganaxolone has received Orphan Drug designation for the treatment of Fragile X Syndrome.
  • Xenetic Biosciences Inc (NASDAQ: XBIO) shares gained 20.5 percent to $4.52.
  • Cempra Inc (NASDAQ: CEMP) surged 16.5 percent to $3.03 after tumbling 57.38 percent on Thursday. Morgan Stanley upgraded Cempra from Underweight to Equal-Weight.
  • ImmunoGen, Inc. (NASDAQ: IMGN) gained 16.5 percent to $1.84. ImmunoGen shares have dropped 88.43 percent over the past 52 weeks, while the S&P 500 index has gained 9.01 percent in the same period.
  • China Cord Blood Corp (NYSE: CO) shares climbed 6.2 percent to $5.81 after Golden Meditech agreed to sell its equity interest in China Cord Blood for RMB5.764 billion in cash.
  • TiGenix - American Depositary Shares (NASDAQ: TIG) shares gained 5.7 percent to $14.78 after dropping 5.87 percent on Thursday.
  • Supercom Ltd (NASDAQ: SPCB) rose 5.2 percent to $3.04 after the company disclosed that it has been awarded a $9 Million secure web land and geographical information system contract by a large Latin America government customer.
  • Nivalis Therapeutics Inc (NASDAQ: NVLS) shares rose 4.9 percent to $2.20 after dropping 2.78 percent on Thursday.
  • Iconix Brand Group Inc (NASDAQ: ICON) rose 3.5 percent to $9.27 after the company reported an agreement to divest Sharper Image brand to ThreeSixty Group for $100 million in cash.
  • National Holdings Corporation (NASDAQ: NHLD) gained 2.3 percent to $2.70. National Holdings reported a FY loss of $0.45 per share on revenue of $174.1 million.

Posted-In: Mid-Day GainersNews Intraday Update Markets Movers


Related Articles (CO + CEMP)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

Tesla The Top Pick For 2017: Baird

Mid-Day Market Update: Opko Health Drops After Disappointing Phase 3 Study of hGH-CTP; Cempra Shares Surge